¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"parabolic inhibition"¿¡ ´ëÇÑ °æºÏ´ëÇб³ Ä¡°ú´ëÇÐ ±¸°³»°úÇб³½Ç »çÀü ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
8
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
¼³¸í
lingering inhibition
lingissimus capitis (µÎÃÖÀå±Ù
»óÃø 4¡5 ÈäÃßÀÇ È¾µ¹±â¿Í ÇÏÃø 3¡4 °æÃßÀÇ °üÀýµ¹±â¿¡¼ ±â½ÃÇÏ¿© ÃøµÎ°ñÀÇ À¯¾çµ¹±â¿¡¼ Á¤ÁöÇÑ´Ù. °æ ½Å°æ °¡ÁöÀÇ Áö¹è¸¦ ¹ÞÀ¸¸ç, ¸Ó¸®¸¦ ÈĹæÀ¸·Î ´ç±â°í ȸÀü½ÃŲ´Ù.
myelinated afferent inhibition
À¯¼öÃÊ ±¸½É¼º ¾ïÁ¦
negative feedback inhibition
À½¼º µÇ¸ÔÀ̱⠾ïÁ¦
noncompetitive inhibition
ºñ°æÇÕÀû ÀúÇØ
postsynaptic inhibition
½Ã³³½º ÈÄ ¾ïÁ¦
segmented inhibition
ºÐÀýµÈ ¹æÇØ
self inhibition
Àڱ⠾ïÁ¦
tonic inhibition
±äÀ强 ¾ïÁ¦
ÀÌÀü
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
¼³¸í
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½